Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello D Bronstein

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Clinical Endocrinology|August 3, 2005
Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institutionRaquel S Jallad, Nina R C Musolino, Luiz R Salgado, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawalVanessa Q Passos, Jean J S Souza, Nina R C Musolino, et al.
Clinical Endocrinology|June 9, 2007
Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?Raquel S Jallad, Nina R Musolino, Sergio Kodaira, et al.
Minerva Endocrinologica|March 16, 2016
Pregnancy and pituitary adenomasAndrea Glezer, Raquel S Jallad, Marcio C Machado, et al.
Neuroendocrinology|September 16, 2008
Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonistsVanessa Q Passos, Maria Angela H Z Fortes, Daniel Giannella-Neto, et al.
Pituitary|December 1, 2016
SOCS2 polymorphisms are not associated with clinical and biochemical phenotypes in acromegalic patientsEricka B Trarbach, Alexander A Jorge, Felipe H Duarte, et al.
European Journal of Endocrinology|March 21, 2015
Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumorsIlan Shimon, Raquel S Jallad, Maria Fleseriu, et al.
Pituitary|November 26, 2013
Multiple facets in the control of acromegalyLucio Vilar, Alex Valenzuela, Antônio Ribeiro-Oliveira, et al.
Pituitary|January 2, 2015
Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegalyRaquel S Jallad, Ericka B Trarbach, Felipe H Duarte, et al.
Pituitary|July 25, 2019
Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation studyAndrea Giustina, Marcello D Bronstein, Philippe Chanson, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Clinical Endocrinology|August 3, 2005
Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institutionRaquel S Jallad, Nina R C Musolino, Luiz R Salgado, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawalVanessa Q Passos, Jean J S Souza, Nina R C Musolino, et al.
Clinical Endocrinology|June 9, 2007
Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?Raquel S Jallad, Nina R Musolino, Sergio Kodaira, et al.
Minerva Endocrinologica|March 16, 2016
Pregnancy and pituitary adenomasAndrea Glezer, Raquel S Jallad, Marcio C Machado, et al.
Neuroendocrinology|September 16, 2008
Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonistsVanessa Q Passos, Maria Angela H Z Fortes, Daniel Giannella-Neto, et al.
Pituitary|December 1, 2016
SOCS2 polymorphisms are not associated with clinical and biochemical phenotypes in acromegalic patientsEricka B Trarbach, Alexander A Jorge, Felipe H Duarte, et al.
European Journal of Endocrinology|March 21, 2015
Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumorsIlan Shimon, Raquel S Jallad, Maria Fleseriu, et al.
Pituitary|November 26, 2013
Multiple facets in the control of acromegalyLucio Vilar, Alex Valenzuela, Antônio Ribeiro-Oliveira, et al.
Pituitary|January 2, 2015
Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegalyRaquel S Jallad, Ericka B Trarbach, Felipe H Duarte, et al.
Pituitary|July 25, 2019
Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation studyAndrea Giustina, Marcello D Bronstein, Philippe Chanson, et al.
Pageof 10